CASP3 and cancer: Despite the fact that untreated 2N and 4N cells showed no statistically significant differences in apoptosis activity, 4N cells showed significantly less caspase 3 activation after treatment with FOLFOX for all cancer cell lines tested (Figure 4A–C).